[bsf-info-box icon_size=”32″ title=”Program overview”]World Cardiac day program is a multidisciplinary event aimed for raising awareness about cardiovascular disease (CVD) and to consider them as a global public health problem. The purpose of the program is to present state of scientific information and to make recommendations for diagnosis and management of different types of adult and congenital cardiac diseases and to establish the knowledge and the important questions in the areas of epidemiology, prevention, pathogenesis, and education. An integrated approach is considered to be essential in order to improve the prevention and care of cardiac diseases in our area and all countries of the world.[/bsf-info-box]
[bsf-info-box icon_size=”32″ icon_animation=”fadeIn” title=”Program objective”]
- Management of Acute Coronary Syndromes (STEMI/NSTEMI)
- Rheumatic Disease and Cardiovascular Disorders
- Overview of Congenital Heart Diseases
- Peri-partum Cardiomyopathy
- Kawasaki Disease and Coronary Artery Aneurysm
- Approach to the New Oral Anticoagulants
- Preparation of Cardiac Patients for Anesthesia
[/bsf-info-box]
[bsf-info-box icon_size=”32″ icon_animation=”fadeIn” title=”Summary of lectures”]Management of Acute Coronary Syndromes (STEMI/NSTEMI)
Acute coronary syndrome (ACS) refers to a group of conditions due to decrease blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left arm or angle of the jaw, pressure- like in character, and associated with nausea and sweating. Acute coronary syndrome usually occurs as a result of one of three problems: ST elevation myocardial infarction (STEMI, 30%), non ST elevation myocardial infarction (NSTEMI, 25%), or unstable angina (38%). These types are named according to the appearance of the electrocardiogram (ECG/EKG) as non-ST segment elevation myocardial infarction and ST segment elevation myocardial infarction.
Acute coronary syndrome (ACS) refers to a group of conditions due to decrease blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left arm or angle of the jaw, pressure- like in character, and associated with nausea and sweating. Acute coronary syndrome usually occurs as a result of one of three problems: ST elevation myocardial infarction (STEMI, 30%), non ST elevation myocardial infarction (NSTEMI, 25%), or unstable angina (38%). These types are named according to the appearance of the electrocardiogram (ECG/EKG) as non-ST segment elevation myocardial infarction and ST segment elevation myocardial infarction.
Strategies for definition, prevention, and treatment are based on an extensive body of information that details the prevalence, distribution, risk implications, and environmental causes of acute coronary syndromes in the population. This lecture reviews current epidemiologic knowledge and the implications of data for prevention and treatment of acute coronary syndromes.[/bsf-info-box]
[bsf-info-box icon_size=”32″ title=”Rheumatic Disease & Cardiovascular Disorders”]The prevalence and importance of cardiovascular disease in rheumatologic disorders have increased in the setting of therapeutic advances, resulting in longer life expectancy, a growing understanding of the nausea and sweating. Acute coronary syndrome usually occurs as a result of one of three problems: ST elevation myocardial infarction (STEMI, 30%), non ST elevation myocardial infarction (NSTEMI, 25%), or unstable angina (38%). These types are named according to the appearance of the electrocardiogram (ECG/EKG) as non-ST segment elevation myocardial infarction and ST segment elevation myocardial infarction.
importance of inflammation and the immune system in the initiation and progression of atherosclerosis, and enhanced disease detection with the use of sophisticated noninvasive cardiac and vascular diagnostic tech Strategies for definition, prevention, and treatment are based on an extensive body of information that details the prevalence, distribution, risk implications, and environmental causes of acute coronary syndromes in the population. This lecture reviews current epidemiologic knowledge and the implications of data for prevention and treatment of acute coronary syndromes.
nology. This article will briefly review cardiovascular manifestations of rheumatologic diseases with an emphasis on recent clinical research[/bsf-info-box]
importance of inflammation and the immune system in the initiation and progression of atherosclerosis, and enhanced disease detection with the use of sophisticated noninvasive cardiac and vascular diagnostic tech Strategies for definition, prevention, and treatment are based on an extensive body of information that details the prevalence, distribution, risk implications, and environmental causes of acute coronary syndromes in the population. This lecture reviews current epidemiologic knowledge and the implications of data for prevention and treatment of acute coronary syndromes.
nology. This article will briefly review cardiovascular manifestations of rheumatologic diseases with an emphasis on recent clinical research[/bsf-info-box]
[bsf-info-box icon_size=”32″ title=”Overview of Congenital Heart Diseases”]Congenital heart defect (CHD), also known as a congenital heart anomaly or congenital heart disease, is a problem in the structure of the heart that is present at birth. Signs and symptoms depend on the specific type of problem. Symptoms can vary from none to life-threatening. When present they may include rapid breathing, bluish skin, poor weight gain, and feeling tired. It does not cause chest pain. Most congenital heart problems do not occur with other diseases. Congenital heart defects are divided into two main groups: cyanotic heart defects and non- cyanotic heart defects, depending on whether the child has the potential to turn bluish in color. The problems may involve the interior walls of the heart, the heart valves, or the large blood vessels that lead to and from the heart. This article will review the most common congenital heart defects and the approach to the diagnosis and treatment.[/bsf-info-box]
[bsf-info-box icon_size=”32″ title=”Peri-Partum Cardiomyopathy”]Peripartum cardiomyopathy (PPCM) is an uncommon disorder associated with pregnancy in which the heart dilates and weakens, leading to symptoms of heart failure. PPCM may be difficult to diagnose because symptoms of heart failure can mimic those of pregnancy. Affected women may recover normal heart function, stabilize on medicines, or progress to severe heart failure requiring mechanical support or heart transplantation. Even when the heart recovers, another pregnancy may be associated with a risk of recurrent heart failure. Important research is underway to understand the cause of PPCM and to develop new treatments.[/bsf-info-box]
[bsf-info-box icon_size=”32″ title=”Kawasaki Disease & Coronary Artery Aneurysm”]Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in 15% to 25% of untreated children and may lead to ischemic heart disease or sudden death. This article will discuss the Treatment of Kawasaki disease in the acute phase that is directed at reducing inflammation in the coronary artery wall and preventing coronary thrombosis, and long- term therapy in individuals who develop coronary aneurysms that is aimed at preventing myocardial ischemia or infarction.
[/bsf-info-box]
[/bsf-info-box]
[bsf-info-box icon_size=”32″ title=”Approach to the New Oral Anticoagulants”]New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with non-valvular atrial fibrillation (AF). Unlike VKAs, these anticoagulants do not require routine INR monitoring and possess favorable pharmacological properties. The lack of an effective antidote, their cost, or reservations in patients with kidney disease may explain their slow rate of expansion. Safe and effective use of these new drugs will depend on clinical experience amongst the medical community. This review discusses the current NOACs, providing practical and easy-to-use algorithms for application in the clinical routine.[/bsf-info-box]
[bsf-info-box icon_size=”32″ title=”Preparation of Cardiac Patients for Anesthesia”]Anesthesia for the patient with heart disease has become increasingly safer with the passage of years due to a better knowledge of the physiology of heart disease and of the pharmacologic action of anesthetic agents themselves. There are few statistics to support the clinical impression that patients with cardiac disease tolerate anesthesia and surgery well but reports are not lacking. This article will review the choice of appropriate anesthetic technique and drugs for the care of cardiac patients requiring anesthesia depending on their risk factors, pre-operative evaluation and strict monitoring.[/bsf-info-box]
